Myriade

Myriade

Paris, France· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.5M

Overview

Myriade is a Paris-based company commercializing a proprietary optical technology, Interferometric Light Microscopy (ILM), for nanoparticle characterization. Its flagship product, Videodrop, provides rapid, single-particle analysis of size and concentration, addressing critical quality control needs in advanced biomanufacturing and nanomedicine research. The company leverages deep academic roots from the Langevin Institute and targets high-growth sectors like cell and gene therapy (viral vectors) and mRNA delivery (LNPs). As a private, early-revenue company, Myriade's strategy is centered on instrument sales and establishing its technology as a standard tool in research and bioproduction workflows.

DiagnosticsDigital HealthAI / Machine Learning

Technology Platform

Interferometric Light Microscopy (ILM): A label-free optical imaging technology that transforms a standard microscope into an interferometer. It uses a LED light source, a high dynamic range camera, and proprietary AI/software algorithms to detect interference patterns from single nanoparticles, enabling rapid measurement of size, concentration, and aggregation kinetics from a micro-volume sample.

Funding History

1
Total raised:$2.5M
Seed$2.5M

Opportunities

The rapid growth of cell/gene therapies and mRNA-based medicines creates surging demand for robust nanoparticle characterization tools for process development and QC.
Expansion of the application set into new nanoparticle types (e.g., synthetic vesicles, protein aggregates) and new markets like synthetic biology can drive sustained instrument sales.

Risk Factors

Competition from established, entrenched techniques (DLS, NTA) and larger instrument companies poses an adoption barrier.
The company's growth is highly correlated with the sometimes-volatile funding and progress of the advanced therapy (CGT, mRNA) sectors it serves.

Competitive Landscape

Myriade competes in the nanoparticle analysis market against established techniques like Dynamic Light Scattering (DLS, e.g., Malvern Panalytical) and Nanoparticle Tracking Analysis (NTA, e.g., Malvern's NanoSight). Key differentiators are Videodrop's speed, single-particle resolution on heterogeneous samples, kinetic aggregation data, and minimal sample volume. It positions itself as a complementary or superior alternative for specific, high-value applications in biotherapeutics.